Connect with us

Abilify (aripiprazole)

Aripiprazole (or ABILIFY®) is mainly prescribed to treat schizophrenia, bipolar disorder, and major depressive disorder.

Status: ACTIVE

Class: Atypical (AAP)

FDA Approval: 2002

Dosage Forms: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg

Biological Half-life: 75 hours

Side Effects: Dizziness, nausea, orthostatic hypotension, constipation, headache, movement problems

Routes of Administration: Oral, Sublingual, IM, IV

Pregnancy Category: C (US)


Twitter Feed

Intense physical exercise may help boost cognition and memory #exercise #wellness #cognition

Feelings of shame could worsen PTSD symptoms in military veterans #PTSD #veterans

Generosity linked to higher self-esteem in adolescents, researchers found